Verma, Sharad K.,

Epigenetics as a paradigm for cancer treatment chemically targeting the histone lysine methyltransferase EZH2 / [electronic resource] : Sharad K. Verma. - London : Henry Stewart Talks, 2015. - 1 online resource (1 streaming video file (21 min.) : color, sound). - The biomedical & life sciences collection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. .

Animated audio-visual presentation with synchronized narration. Title from title frames.

Contents: Cancer as an unmet medical need -- Epigenetics as a paradigm for treating cancer -- Histone lysine methyltransferase EZH2 as a target class example -- Development of EZH2 inhibitors.

Access restricted to subscribers.


Mode of access: World Wide Web.

4131 Henry Stewart Talks


Cancer--Genetic aspects.
Cancer--Treatment.
Epigenesis.
Antineoplastic Agents--pharmacology.
Drug Discovery--methods.
Epigenesis, Genetic--drug effects.
Epigenesis, Genetic.
Histone-Lysine N-Methyltransferase--antagonists & inhibitors.
Histones--metabolism.
Methyltransferases--antagonists & inhibitors.
Molecular Targeted Therapy--methods.
Neoplasms--diagnosis.
Neoplasms--drug therapy.
Neoplasms--genetics.
Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571